References
Araujo P (2009) J Chromatogr B 877:2224–2234
Tsikas D (2009) J Chromatogr B 877:2244–2251
Matuszewski BK (2006) J Chromatogr B 830:293–300
Tsikas D (2009) J Chromatogr B 877:2308–2320
Martens-Lobenhoffer J, Schwedhelm E, Tsikas D (2009) J Chromatogr B 877:3261–3266
Teerlink T (2005) Clin Chem Lab Med 43:1130–1138
Schwedhelm E (2005) Vasc Med (Suppl 1) S89–95
Teerlink T (2007) J Chromatogr B 851:21–29
Horowitz JD, Heresztyn T (2007) J Chromatogr B 851:42–50
Martens-Lobenhoffer J, Bode-Böger SM (2007) J Chromatogr B 851:30–41
Tsikas D (2008) Curr Opin Clin Nutr Metab Care 11:592–600
Schwedhelm E, Xanthakis V, Maas R, Sullivan LM, Schulze F, Riederer U, Benndorf RA, Böger RH, Vasan RS (2009) Clin Chem 55:1539–1545
Lücke T, Kanzelmeyer N, Kemper MJ, Tsikas D, Das AM (2007) Clin Chem Lab Med 45:1525–1530
Wang HY, Hu P, Jiang J (2009) Chromatographia 71:933–939
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsikas, D. Quantification of Circulating Asymmetric Dimethylarginine (ADMA) in Humans: Consideration of Reference Intervals and Inter-Individual Variability in Method Validation. Chroma 72, 767–769 (2010). https://doi.org/10.1365/s10337-010-1689-4
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-010-1689-4